Benjamin Edwards Inc Intellia Therapeutics, Inc. Transaction History
Benjamin Edwards Inc
- $6.78 Billion
- Q4 2024
A detailed history of Benjamin Edwards Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 64,065 shares of NTLA stock, worth $646,415. This represents 0.01% of its overall portfolio holdings.
Number of Shares
64,065
Previous 57,669
11.09%
Holding current value
$646,415
Previous $1.19 Million
37.05%
% of portfolio
0.01%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$126 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$103 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$96.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$52.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$38.5 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $767M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...